Jose Wippold is adapting an existing microfluidic sensor he developed to look for antibodies that can fight against the disease caused by the novel coronavirus.
A Texas A&M team received a National Science Foundation grant to pursue the 'lab-on-a-chip' technology to rapidly identify antibodies for therapeutics to fight COVID-19.
Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.
Despite federal red tape limiting testing capacity, the Veterinary Medical Diagnostic Laboratory in College Station began limited human testing this week.
Scientists are recruiting hundreds of medical workers to test the existing vaccine's ability to mitigate the effects of the illness. Results are expected within six months.